Core Insights - INNOVATE reported strong revenue growth for the fourth quarter and full year 2025, with consolidated revenue of $382.7 million for Q4, up 61.7% year-over-year, and full-year revenue of $1.2 billion [4][8]. - The company experienced a narrowing of net loss to $7.8 million in Q4 2025, compared to a net loss of $16.9 million in Q4 2024 [3][8]. - The infrastructure segment, particularly DBM Global, was a key driver of revenue growth, although it faced margin pressures [5][7]. Infrastructure Segment - DBM Global delivered fourth-quarter revenue of $373.9 million and adjusted EBITDA of $28.0 million, contributing significantly to the overall performance [1][5]. - The adjusted backlog for DBM Global increased to approximately $1.8 billion, up from $1.1 billion at the end of 2024, indicating strong future project commitments [9][10]. - Despite revenue growth, DBM Global experienced gross margin compression of about 350 basis points to 14.7% and adjusted EBITDA margin fell to 7.5% [7][9]. Life Sciences Segment - MediBeacon achieved FDA approval for its next-generation TGFR system, which is expected to enhance patient comfort and economic value [6][13]. - R2, another life sciences business, reported record annual revenue of $12.5 million for 2025, up approximately 28% year-over-year, driven by international demand [17][18]. - R2's fourth-quarter revenue was $3.1 million, down from $4.1 million in the prior-year quarter, primarily due to inventory constraints [16]. Spectrum Segment - The Spectrum segment reported fourth-quarter revenue of $5.7 million, facing challenges from a soft advertising environment [19][23]. - New network launches are ongoing, including targeted channels for specific audiences, which may improve future revenue [20]. - Spectrum is also working on a joint venture with a mobile wireless carrier and has received support for its FCC petition to convert low-power TV stations to 5G Broadcast [21][22]. Financial Overview - INNOVATE ended 2025 with $112.1 million in cash and cash equivalents, a significant increase from $48.8 million at the end of 2024 [24]. - The company had $687.2 million in principal outstanding indebtedness, up from $668.3 million at the end of 2024, attributed to refinancing transactions [25].